AMAG Pharmaceuticals Inc. (Nasdaq: AMAG) provided preliminary fourth quarter and full year results sending the stock price plummeting $12.70 to close at $23.00.
AMAG Pharmaceuticals provides preliminary results
January 09, 2017 at 19:17 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.